Takeda's Response to COVID-19 If you were diagnosed with COVID-19 and have recovered, you may be able to help in furthering research into a potential therapy for others by donating your plasma.

A multi-centre observational study to describe the impact of vedolizumab on concomitant prescribing and quality of life in patients with ulcerative colitis and Crohn’s disease in the UK and Ireland

IDENTIFIERS
Trial Protocol: Vedolizumab-5044
EUPAS: EUPAS22954
PURPOSE

This is a part retrospective, part prospective, multi-center, observational study for patients with ulcerative colitis (UC) or Crohn’s disease (CD). The study will review the medical records of patients to provide real-world evidence related to the impact of vedolizumab on corticosteroid, immunomodulator and antibiotic prescribing.

Recruiting
GB

Trial at a glance

What medical condition is being studied?   Inflammatory Bowel Disease
When is the trial being conducted?   

Key requirements

Sex   
All
Age   
From 18 Years
Accepts Healthy Volunteers?   
No

Trial Details / Participation Requirements

CLICK TO EXPANDCLICK TO COLLAPSE
Trial Type:   Observational